2024 · Clinical and translational science · open access
Safety of BI 1358894 in patients with major depressive disorder: Results and learnings from a phase II randomized decentralized clinical trial
Reist et al.
The finding, in our words
A fully remote phase II trial in major depressive disorder was terminated early due to poor recruitment but demonstrated feasibility with a 97.7% completion rate and 88% positive patient experience, highlighting the need to optimise eligibility criteria and recruitment strategies for future decentralised interventional studies.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.